Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus propofol sedation for short invasive procedures in pediatric oncology
ACTRN12613000149763Phase 2Not yet recruiting
- Sponsor
- Ahmad ramzy
- Start
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of dexmedetomidine, propofol and ketamine, sponsored by Ahmad ramzy. Planned start May 2013; status: not yet recruiting.
02
Drugs
dexmedetomidinepropofolketamine
Beyond the preview
Go deeper on ACTRN12613000149763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613000149763.